Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,141
Closed -$151K 451
2017
Q4
$151K Buy
3,141
+10
+0.3% +$474 0.01% 152
2017
Q3
$144K Buy
3,131
+11
+0.4% +$477 0.01% 146
2017
Q2
$138K Buy
3,120
+12
+0.4% +$504 0.01% 130
2017
Q1
$128K Buy
3,108
+9
+0.3% +$375 0.01% 138
2016
Q4
$127K Buy
3,099
+11
+0.4% +$405 0.01% 129
2016
Q3
$100K Buy
+3,088
New +$97K 0.01% 120

Other funds holding SNV

Balentine LLC's SNV Position: Q1 2018 in Review

Balentine LLC sold out of Synovus (SNV) in Q1 2018, closing a stake of 3,141 shares — an estimated $151K sold.

Balentine LLC first reported a position in SNV in Q3 2016 and held it in 6 quarters. The position peaked at $151K in Q4 2017. 324 funds tracked by Wall St. Rank hold SNV as of Q1 2018.

  • Balentine LLC reported no remaining Synovus position as of Q1 2018 after selling out during the quarter.
  • Balentine LLC sold 3,141 Synovus shares in Q1 2018, an estimated $151K.
  • Balentine LLC first reported a position in Synovus in Q3 2016 and held it in 6 quarters.
  • Balentine LLC's Synovus position peaked at $151K in Q4 2017.
  • 324 funds tracked by Wall St. Rank held Synovus as of Q1 2018.

Based on Balentine LLC's 13F filing for Q1 2018, filed 16 May 2018.